Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Drug Interactions MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

CYTOFLAVIN is indicated as additional therapy to standard therapy for: Moderate stage of acute ischaemic stroke, to be administered within the first 6-24 hours after the onset of stroke symptoms; the residual symptoms (sequelae) of ischemic stroke which occurred within the previous 25-30 days.

Cytoflavin Indications/Uses

Manufacturer:

Pyridam